The perceived promise of p19 inhibitors
- PMID: 30222877
- DOI: 10.1111/bjd.16941
The perceived promise of p19 inhibitors
Comment on
-
Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials.Br J Dermatol. 2018 Sep;179(3):615-622. doi: 10.1111/bjd.16724. Epub 2018 Jul 4. Br J Dermatol. 2018. PMID: 29742274
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical